Apeiron Capital »

Nektar Therapeutics shares owned by Apeiron Capital

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Apeiron Capital from 13F filings

Historical chart of Apeiron Capital investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Apeiron Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Apeiron Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.4M 106k 69.81

More positions owned by Apeiron Capital

Direxion Daily Mu Bull 2x Et Dly Mu Bull 2x (MUU)
On Holding Ag-class A Namen Akt A (ONON)
Abivax Sa- Sponsored Ads (ABVX)
Qfin Holdings Inc- American Dep (QFIN)
Summit Therapeutics (SMMT)
Taiwan Semiconductor-sp Sponsored Ads (TSM)
Western Digital (WDC)
Nektar Therapeutics Com New (NKTR)
Nokia Corp- Sponsored Adr (NOK)
Seagate Technology Holdings Ord Shs (STX)
Sandisk Corp (SNDK)
Lumentum Hldgs (LITE)
Trip.com Group Ltd- Ads (TCOM)
Poet Technologies Com New (POET)

View all positions for Apeiron Capital

Top funds holding Nektar Therapeutics

FMR
BVF
Two Seas Capital
Vanguard Capital Management
Two Sigma Investments
Susquehanna International
Prosight Management
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Sofinnova Ventures
Woodline Partners
Lord, Abbett & Co

View all funds holding Nektar Therapeutics